Healthcare Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Bristol-Myers Squibb (NYSE:BMY), Merck & Co. (NYSE:MRK), Gilead Sciences (NASDAQ:GILD)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) on Feb. 25 reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened at $7.71 in last session, and closed at $7.77, while the day range of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock is $7.60 – $7.86. The stock showed a positive weekly performance of -9.44%.

Bristol-Myers Squibb Co. (NYSE:BMY) announced that its new drug nivolumab plus Yervoy will move to a Phase III trial in non-small cell lung cancer (NSCLC) by year end. Bristol-Myers Squibb Co (NYSE:BMY) stock opened at $55.29 in last session, and closed at $55.24 by losing -1.06%. The 52 week range of $37.53 – $57.49. Company’s market capitalization is $91.15 billion.

Merck & Company, Inc. (NYSE:MRK) begin trading ex-dividend on March 13, 2014. A cash dividend payment of $0.44 per share is scheduled to be paid on April 07, 2014. Merck & Co., Inc. (NYSE:MRK) stock increased 0.21% and finished the last session at $56.81. The EPS of the stock remained 1.48. Company’s market capitalization is $166.28 billion.

One such company that might be well-positioned for future earnings growth is Gilead Sciences Inc. (NASDAQ:GILD). This firm, which is in the Biotechnology industry, saw EPS growth of 10.9% last year, and is looking great for this year too. Gilead Sciences, Inc. (NASDAQ:GILD) stock opened the session at $79.36, and closed the session at $79.72. The 52 week range of the Gilead Sciences, Inc. (NASDAQ:GILD) stock remained $43.78 – $84.88 and the day range was $78.62 – $80.30.